Tianhong Hang Seng Shanghai-Shenzhen-Hong Kong Innovative Drug Select 50 Index Exchange Traded Fund (517380.SS) Price

Tianhong Hang Seng Shanghai-Shenzhen-Hong Kong Innovative Drug Select 50 Index Exchange Traded Fund is offered by Tianhong, a leading player in the field of passive investments.

The ISIN of Tianhong Hang Seng Shanghai-Shenzhen-Hong Kong Innovative Drug Select 50 Index Exchange Traded Fund is CNE100004XJ0.

European investors may incur additional costs for currency exchange and transaction fees.

No, Tianhong Hang Seng Shanghai-Shenzhen-Hong Kong Innovative Drug Select 50 Index Exchange Traded Fund does not comply with the EU UCITS investor protection directives.

Tianhong Hang Seng Shanghai-Shenzhen-Hong Kong Innovative Drug Select 50 Index Exchange Traded Fund tracks the performance of the Hang Seng Shanghai-Shenzhen-Hong Kong Innovative Drug Select 50 Index - CNY - Benchmark TR Gross.

Tianhong Hang Seng Shanghai-Shenzhen-Hong Kong Innovative Drug Select 50 Index Exchange Traded Fund is domiciled in CN.

The fund was launched on 7/27/2021.

The Tianhong Hang Seng Shanghai-Shenzhen-Hong Kong Innovative Drug Select 50 Index Exchange Traded Fund mainly invests in Healthcare companies.

Investments can be made through brokers or financial institutions that provide access to trading ETFs.

The ETF is traded on the stock exchange, similar to stocks.

Yes, the ETF can be held in a regular securities account.

The ETF is suitable for both short-term and long-term investment strategies, depending on the investor's goals.

The ETF is valued on a daily stock exchange basis.

Information on dividends should be requested from the provider's website or your broker.

The risks include market fluctuations, currency risks, and the risk associated with smaller companies.

The ETF is obligated to report regularly and transparently on its investments.

The performance can be viewed on Eulerpool or directly on the provider's website.

Further information can be found on the official website of the provider.